| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Revenue | $1.27B | -2.0% |
| Cost of Revenue | $140.5M | -7.9% |
| Gross Profit | $1.13B | -1.2% |
| R&D Expense | $263.7M | -2.9% |
| SG&A Expense | $270.4M | +4.6% |
| Operating Income | $258.3M | +19.7% |
| Pre-tax Income | $312.5M | +25.0% |
| Income Tax | $48.2M | -0.5% |
| Net Income | $261.8M |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $482.0M | -35.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $315.5M | +20.3% |
| Inventory | $33.7M | -5.3% |
| Current Assets | $1.19B | -19.7% |
| Total Assets | $3.11B | +4.4% |
| Current Liabilities | $417.8M | -1.0% |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $327.3M | -10.9% |
| Capital Expenditures | $30.0M | -1.1% |
| Investing Cash Flow | -$286.3M | -628.2% |
| Financing Cash Flow | -$287.8M | -21.5% |
| Free Cash Flow | $297.2M | -11.7% |
| +30.5% |
| EPS (Basic) | $2.74 | +30.5% |
| EPS (Diluted) | $2.69 | +31.2% |
| Total Liabilities |
| $623.0M |
| +2.5% |
| Stockholders' Equity | $2.48B | +5.2% |